Compare IMVT & FRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | FRO |
|---|---|---|
| Founded | 2018 | 1985 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.8B |
| IPO Year | 2019 | 1995 |
| Metric | IMVT | FRO |
|---|---|---|
| Price | $24.02 | $33.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $30.78 | ★ $32.67 |
| AVG Volume (30 Days) | 997.2K | ★ 4.6M |
| Earning Date | 02-06-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 5.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.72 | $12.40 |
| 52 Week High | $29.25 | $39.89 |
| Indicator | IMVT | FRO |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 53.10 |
| Support Level | $22.00 | $21.93 |
| Resistance Level | $24.63 | $39.89 |
| Average True Range (ATR) | 1.16 | 1.32 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 32.41 | 60.58 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.